RCTs


The effect of allopurinol on carotid ultrasound intima-media thickness and markers of endothelial function in patients with recent stroke (Allo-IMT; UK)

Matthew Walters; Prof.
Jesse Dawson; Dr.
Peter Higgins; Dr.


Asymptomatic Carotid Artery Progression Study (ACAPS; USA)

Mark A. Espeland; PhD, Prof.



Actos Now for the prevention of diabetes study (Actos Now; USA)

Ralph A. DeFronzo; MD, Prof.
Devjit Tripathy; MD, PhD, Assoc. Prof.
Peter Reaven; MD, Prof.


Atorvastatin vs Simvastatin on Atherosclerosis Progression (ASAP-NL)

Eric de Groot, MD, PhD
Tineke J Smilde, MD, PhD
Anton Stalenhoef, MD, PhD



Atherogenicity Monitoring and Atherosclerosis Regression Study (AMAR; Russia)

Igor A. Sobenin; MD, PhD, DSc
Alexander N. Orekhov; PhD, DSc
Veronica A. Myasoedova; MD, PhD


Atherosclerosis and Folic Acid Supplementation Trial (ASFAST; Australia)

Barry McGrath; MBBS, MD, Prof.
John McNeil; MBBS, PhD, Prof.
Sophia Zoungas; MBBS, Assoc. Prof.


Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC; Netherlands)

Coen D.A. Stehouwer; MD, PhD, Prof.
Pieter M. ter Wee; MD, PhD, Prof.
Prabath Nanayakkara; MD, PhD




Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant (AUDITOR)

John JP Kastelein; MD, Prof.
Eric de Groot; MD, PhD
Joseph Polak; MD, Prof


Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study
(BCAPS; Sweden)

Gunnar Engström; MD, PhD, Assoc. Prof.
Bo Hedlbad; MD, PhD, Prof.
Maria Rosvall; MD, PhD, Assoc. Prof.


BK Registry II (South Korea)

Jang-Ho Bae; MD, PhD, Prof.
Hyung-Woong Park; MD, Assoc. Prof.
Moo-Sik Lee; MD, PhD, Prof.


Carotid Atherosclerosis: MEtformin for Insulin REsistAnce study (CAMERA; UK)

Naveed Sattar; MD, PhD, Prof.
David Preiss; MD


Carotid Atherosclerosis Progression Trial Investigating Vascular ACAT Inhibition (CAPTIVATE; Netherlands)

Eric de Groot; MD, PhD




Cerdia (Netherlands)

Menno Huisman; MD, PhD
Shari Pasha; MD
Edith Beishuizen; MD



A randomised controlled trial to examine the effects of calcimimetic therapy on bone and cardiovascular health in end-stage renal disease
(Cinacalcet; UK)


Helen Eddington; MD
Philip A Kalra; MD, PhD, Prof.


Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients (CONTRAST)

Michiel L Bots; MD, PhD, Prof.



Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients (EGESTUDY; Turkey)

Ercan Ok; MD, PhD, Prof.
Gülay Aşçi; MD, PhD, Prof.

 

Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE; Netherlands)

Eric de Groot; MD, PhD

 

 

Exercise and Nutritional Interventions for Cardiovascular Health (ENCORE; USA) 

James Blumenthal; PhD
Andrew Sherwood; PhD
lan Hinderliter; MD
Patrick Smith; MPH

 

 

Folic Acid and Carotid Intima-media Thickness Study (FACIT)

Michiel L Bots; MD, PhD, Prof.




Glucose Reduction and Atherosclerosis Continuing Evaluation Study (GRACE; Canada)

Eva Lonn; MD, MSc
Herztel C. Gerstein; MD, MSc
Leanne Dyal; MSc

 

Gifu Ultrasound and MRI Study of Carotid Atherosclerosis (Japan)

Masanori Kawasaki; MD, Assoc. Prof.
Kiyofumi Yamada; MD, PhD
Shinichi Yoshimura; MD, Assoc. Prof.



Heart Outcomes Prevention Evaluation/Homocysteine and Atherosclerosis Reduction Trial (HART; Canada) 
 
Eva Lonn; MD, MSc
Salim Yusuf; MD, DPhil
Jackie Bosch; MSc

 

 

Hypertension High Risk Management (HYRIM; Norway)

Sigmund A. Anderssen; PhD, Prof.
Ingar M.K. Holme; PhD, Prof.



Effect of Magnesium Oxide on Improvement of Carotid intima media Thickness in hemodialysis patients (Iran)

Mohammed Saadatnia; MD, Assoc. Prof.
Mojgan Mortazavi; MD, Assoc. Prof.
Firouzeh Moeinzadeh; MD




Vitamin K to Improve Markers of Vascular Health and Physical Function in Older People with Vascular Disease (KIMVASC; UK)

Miles D. Witham; Dr.



Losartan Intervention For Endpoint-reduction in hypertension

(LIFE; Denmark/Norway)

Severre E. Kjeldsen; MD, PhD, Prof.
Michael Hecht Olsen; MD, PhD, Prof.
Kristian Wachtell; MD, PhD


Effects of Lutein Supplementation on Early Atherosclerosis (Lin et al.; China)

Zhi-Yong Zou; MD
Dongmei Ma; MSc
Zhenghe Wang; MD


Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis (Liu et al.; China)

Zhendong Liu; MD, Prof.
Yingxin Zhao; MD
Hua Zhang; PhD

Long-term Intervention with Pravastatin in Ischemic Disease (LIPID; New Zealand)

Norman Sharpe; MD, Prof.
Gillian Whalley; PhD, Prof.
Greg Gamble; MSc


Malmö Plaques Subcohort (Sweden)

Gunnar Engström; MD, PhD, Assoc. Prof.
Bo Hedblad; MD, PhD, Prof.
Maria Rosvall; MD, PhD, Assoc. Prof.

 

 Masiá et al. (Spain)

Félix Gutiérrez; MD, PhD
Enrique Bernal; MD, PhD
Mar Masiá; MD, PhD

 

Melbourne Atherosclerosis Vitamin E Trial (MAVET; Australia)


John McNeil, PhD, Prof.
Dianna Magliano, MPH, PhD,Assoc. Prof.
Sophia Zoungas, PhD, Assoc. Prof.



Metabolic Effects of Different Classes of AntiretroviralS
(MEDICLAS; Netherlands)

M.G.A. van Vonderen; MD, PhD
P. Reiss; MD, PhD, Prof.
M.A. van Agtmael; MD, PhD


Effects of Magnesium Supplementation on Vascular Structure and Function in Hypertensive Patients (MG600; Brazil)

Mario Fritsch Neves; MD, PhD, Prof.
Wille Oigman; MD, PhD, Prof.
Ana Rosa Cunha; MSc, PhD


Nakamura et al (Japan)

Mayuko Amaha; MD
Tsukasa Nakamura; MD, PhD
Eiichi Sato; MD, PhD



Nakamura et al II (Japan)

Mayuko Amaha; MD
Tsukasa Nakamura; MD, PhD
Eiichi Sato; MD, PhD



NCX-4016-X-208 study (Italy)

Paolo Gresele; MD, PhD, Prof.
Rino Migliacci; MD
Guiseppe Guglielmini; MD, PhD



Ntaios et al (Greece)

Apostolos Hatzitolios; MD, PhD, Prof.
George Ntaios; MD, Prof.
Christos Savapoulos; MD, PhD, Prof.



Oral Fibrinogen-depleting Agent Lumbrokinase for Secondary Prevention of Ischemic Sroke: Results from the multicenter, randomized, parallel-group and controlled Clinical Trial (OFBLSP-Suzhou; China) 

Chun-Feng Liu, MD, PhD, Prof.
Yong-Jun Cao, MD, PhD
Xia Zhang, MD



Osteoporosis Prevention and Arterial efects of tiboLone (OPAL; Netherlands)

Michiel Bots; MD, PhD, Prof.
Frans Helmond; PhD
Gregory Evans; MA


Prevention of Atherosclerosis with Ramipril Treatment (Part-2; New Zealand)

Norman Sharpe; MD, Prof.
Gillian Whalley; PhD, Prof.
Greg Gamble; MSc


PerioCardio Study (Australia)

Lisa M. Jamieson; Assoc. Prof.
Michael Skilton; PhD
Kostas Kapellas;



PREvención con DIeta MEDiterránea (PREDIMED; Spain)

Ramon Estuch; MD, PhD
Emilio Ros; MD, PhD
Estefania Toledo; PhD



Prevention of Renal and Vascular ENDstage Disease Intervention Trial

(PREVEND  IT; Netherlands)

Folkert W. Asselbergs; MD, PhD, Assoc. Prof.
Frank P.J. Brouwers; MD
Wiek H. van Gilst; PhD, Prof.



Effect of CSII and CGM on Progression of Late Diabetic Complications
(PUMA; Denmark)

Peter Rossing; MD, DMSc, Prof.
Steen Andersen; MD, DMSc
Signe Rosenlund; MD




Pleiotropic effects of nicotinic acid therapy in men with coronary elevated lipoprotein (a) levels Study (Russia)

Tatyana Balakhonova; MD, PhD, Prof.
Marat Ezhov; MD, PhD
Maya Safarova; MD


Rating Atherosclerosis Disease Change by Imaging with a New CETP Inhibitor 1 (RADIANCE 1; Netherlands)

Michiel Bots; MD, PhD, Prof.
Gregory Evans; MA
Diederick E. Grobbee; MD, PhD, Prof.
John JP Kastelein; MD, Prof.



Rating Atherosclerosis Disease Change by Imaging with a New CETP Inhibitor 2 (RADIANCE 2; Netherlands)

Michiel Bots; MD, PhD, Prof.
Gregory Evans; MA
John JP Kastelein; MD, Prof.
Frank L.J. Visseren; MD, Prof.



Regression Growth Evaluation Statin Study (REGRESS; Netherlands)

Eric de Groot; MD, PhD



Risk Factor Intervention Study (RIS; Norway)

Stefan Agewall; MD, PhD, Prof.
Björn Fagerberg; MD, PhD, Prof.
Caroline Schmidt; PhD



Rosiglitazone and Atherosclerosis Study (RAS; Sweden)

Gunnar Engström; MD, PhD, Assoc. Prof.
Bo Hedblad; MD, PhD, Prof.
Maria Rosvall; MD, PhD, Assoc. Prof.



Sander et al (Germany)

Dirk Sander; MD, Prof.
Etgen Thorleif; MD, PhD
Kerstin Sander; MD, PhD

 

 

Heart Outcomes Prevention Evaluation/Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril (SECURE; Canada) 
 
Eva Lonn; MD, MSc
Salim Yusuf; MD, DPhil
Janice Pogue; PhD



Secondary prevention for inpatients with coronary artery disease in rehabilitation and conceptual aftercare (Sekona; Germany)
 
Wolfgang Mayer-Berger; MD, PhD


The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD; Taiwan) 
 
Chung Y. Hsu; MD, PhD, Prof
Jiann-Shing Jeng ; MD, Prof
Yu Sun; MD

STudy of Atherosclerosis with Ramipril and Rosiglitazone (STARR; Canada) 
 
Eva Lonn; MD, MSc
Herztel C. Gerstein; MD, MSc
Patrick Sheridan; MSc

 

Study to Prevent Non-Insulin-Dependent Diabetes Mellitus (STOP-NIDDM; Bulgary, Germany)
 
Theodora Temelkova-Kurktschiev; PhD, Prof
Markolf Hanefeld; PhD, Prof


Tasić et al. (Serbia)
 
Ivan Tasic; MD, PhD, Prof
Dragan Mijalković; MD, PhD
Svetlana Kostic; MSc, MD, PhD


Tungkasereerak et al. (Thailand)
 
Wattana Leowattana; Assoc. Prof.


Vital Study (Netherlands)

Erik Stroes; MD, PhD
Pythia Nieuwkerk; PhD



Wessex Evaluation of fatty Liver and Cardiovascular markers in NAFLD with OMacor therapy (WELCOME; UK) 

Philip C. Calder; MD, PhD, Prof.
Lokpol Bhatia; MD, PhD
Christopher D. Byrne; MD, PhD, Prof.



Yu et al. (Taiwan)

Chen-Huan Chen; Prof, MD
Yao-Ping Lin; MD
Wen-Chung Yu; MD, Assoc. Prof






Home    Background    The Project
Study Group    Evolution    Publications
Your Data    Contact